Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports

Author:

Prieto González José María1,Vila Silván Carlos2

Affiliation:

1. Jefe Del Servicio De Neurología/Neurology Service Head, Hospital Clínico Universitario, Santiago De Compostela, Spain

2. Global Medical Affairs, Almirall S.A., Barcelona, Spain

Funder

Almirall S.A

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Clinical Neurology,General Neuroscience

Reference44 articles.

1. A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol

2. Sativex oromucosal spray. Summary of product characteristics; August 2020. GW Pharma Ltd. Available at: https://www.medicines.org.uk/emc/product/602/smpc#gref [Accessed 2020 Oct 9].

3. Sativex® oromucosal spray. Summary of product characteristics; September 2012. Neopharm Scientific Ltd. Available at: http://www.pharmaline.co.il/images/newsletterregistration/neopharm/2012/03092012/sativex_dr.pdf [Accessed 2020 Oct 9].

4. European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3